News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Denis Jardim: Hispanics are highly underrepresented in oncology clinical trials by Dr. Cheryl Lee
Photo taken from: Denis Jardim/X
Jan 28, 2024, 13:41

Denis Jardim: Hispanics are highly underrepresented in oncology clinical trials by Dr. Cheryl Lee

Denis Jardim, Chief of GU Cancer at Grupo Oncoclínicas, made the following post on X:

“Hispanics are highly underrepresented in oncology clinical trials. We need to close this gap supporting patients and investigators from LATAM. Terrific keynote lecture by Dr. Cheryl Lee during GU24.”

Source: Denis Jardim/X

cancer Cheryl Lee Denis Jardim OncoDaily Oncology
Special Coverage
Blog
Feb 26, 2025, 14:04
Sami (Papacek) Mansfield: The discussion of myokines in cancer is exciting
Career
Feb 26, 2025, 13:39
Dan Theodorescu has been appointed as the Director of University of Arizona Cancer Center
Science
Feb 26, 2025, 13:37
Olivier Elemento: How do early lung tumors evolve?
Drugs
Feb 26, 2025, 13:29
FDA approves Vimseltinib(Romvimza) for symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Blog
Feb 26, 2025, 12:12
David Korn: Honoring the legacy of Professor Giovanni Scambia
Science
Feb 26, 2025, 12:06
Emad Shash: The role of adjuvant radiotherapy in postmenopausal women with early-stage ER+ breast cancer
Blog
Feb 26, 2025, 11:56
The FDA has approved vimseltinib by Deciphera Pharmaceuticals for TGCT - The Babak Lab
Blog
Feb 26, 2025, 11:46
Karan Cushman: Can AI Help CURE Cancer?
Blog
Feb 26, 2025, 11:46
A Milestone for Children's Palliative Care in Ghana - World Child Cancer
Blog
Feb 26, 2025, 11:44
Michael Chuong: The second special edition for SBRT/SRS in Cancers
Science
Feb 26, 2025, 11:40
Jasmine Kamboj: Our patients are more than their cancer diagnoses
Blog
Feb 26, 2025, 11:15
Cristian Ochoa Arnedo: Vital Impact in the face of cancer